Tom 17, Nr 2 (2020)
Wytyczne / stanowisko ekspertów
Opublikowany online: 2020-10-14
Wyświetlenia strony 409
Wyświetlenia/pobrania artykułu 47
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Miejsce sildenafilu w leczeniu zaburzeń erekcji — interdyscyplinarne stanowisko ekspertów z uwzględnieniem nowo zarejestrowanej dawki 50 mg dostępnej bez recepty

Filip M. Szymański1, Krzysztof Narkiewicz2, Zbigniew Lew-Starowicz3, Janusz Gumprecht4, Tomasz Szopiński5, Krzysztof J. Filipiak1
Choroby Serca i Naczyń 2020;17(2):77-83.

Streszczenie

Brak

Artykuł dostępny w formacie PDF

Dodaj do koszyka: 49,00 PLN

Posiadasz dostęp do tego artykułu?

Referencje

  1. Raport "Seksualność Polaków 2017". https://mediarun.com/pl/marketing/seksualnosc-polakow-2017-nadal-jestesmy-grzeczni-powsciagliwi-pelne-wyniki.html (June 30, 2020).
  2. Fang SC, Rosen RC, Vita JA, et al. Changes in erectile dysfunction over time in relation to Framingham cardiovascular risk in the Boston Area Community Health (BACH) Survey. J Sex Med. 2015; 12(1): 100–108.
  3. Hatzichristou D, Kirana PS, Banner L, et al. Diagnosing sexual dysfunction in men and women: sexual history taking and the role of symptom scales and questionnaires. J Sex Med. 2016; 13(8): 1166–1182.
  4. Viigimaa M, Vlachopoulos C, Doumas M, et al. European Society of Hypertension Working Group on Sexual Dysfunction. Update of the position paper on arterial hypertension and erectile dysfunction. J Hypertens. 2020; 38(7): 1220–1234.
  5. Viigimaa M, Doumas M, Vlachopoulos C, et al. European Society of Hypertension Working Group on Sexual Dysfunction. Hypertension and sexual dysfunction: time to act. J Hypertens. 2011; 29(2): 403–407.
  6. Williams B, Mancia G, Spiering W, et al. ESC Scientific Document Group . 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33): 3021–3104.
  7. Dong JY, Zhang YH, Qin LQ. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2011; 58(13): 1378–1385.
  8. Szymański FM, Puchalski B, Filipiak KJ. Obstructive sleep apnea, atrial fibrillation, and erectile dysfunction: are they only coexisting conditions or a new clinical syndrome? The concept of the OSAFED syndrome. Pol Arch Med Wewn. 2013; 123(12): 701–707.
  9. La Torre A, Giupponi G, Duffy D, et al. Sexual dysfunction related to drugs: a critical review. Part IV: cardiovascular drugs. Pharmacopsychiatry. 2015; 48(1): 1–6.
  10. International Diabetes Federation. IDF Diabetes atlas 9th edn. https://diabetesatlas.org/en/resources/ (June 30, 2020).
  11. Kessler A, Sollie S, Challacombe B, et al. The global prevalence of erectile dysfunction: a review. BJU Int. 2019 [Epub ahead of print].
  12. Gandhi J, Dagur G, Warren K, et al. The role of diabetes mellitus in sexual and reproductive health: an overview of pathogenesis, evaluation, and management. Curr Diabetes Rev. 2017; 13(6): 573–581.
  13. Kouidrat Y, Pizzol D, Cosco T, et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med. 2017; 34(9): 1185–1192.
  14. Hatzimouratidis K, Salonia A, Adaikan G, et al. Pharmacotherapy for erectile dysfunction: recommendations from the Fourth international Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016; 13(4): 465–488.
  15. Bhasin S, Cunningham GR, Hayes FJ, et al. Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010; 95(6): 2536–2559.
  16. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med. 1998; 338(20): 1397–1404.
  17. Ahmed M, Kumari S, Manali P, et al. Safety and quality concerns regarding over-the-counter sexual enhancement products sold in the USA market pose a major health risk. J Addict Res Ther. 2016; 7(5).
  18. Platek AE, Hrynkiewicz-Szymanska A, Kotkowski M, et al. Prevalence of erectile dysfunction in atrial fibrillation patients: a cross-sectional, epidemiological study. Pacing Clin Electrophysiol. 2016; 39(1): 28–35.
  19. Puchalski B, Szymański F, Kowalik R, et al. [Sexual dysfunction in men in the first 9 months after myocardial infarction] [Article in Polish] . Psychiatr Pol. 2013; 47(5): 811–826.
  20. Lew-Starowicz Z, Filipiak KJ, Januszewicz A, Radziszewski P, Mamcarz A, Lew-Starowicz M, Prejbisz A, Puchalski B, Szeligowska J. Kardioseksuologia. Wydanie 4. Wyd. Medical Education, Warszawa 2011.